Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are naturally occurring hormones that regulate appetite, insulin secretion, and metabolism
Although some research has been done on BPC-157, the data can only be considered preliminary
GLP-1 medications help the body manage blood sugar more efficiently, which can lead to steadier energy, fewer glucose spikes, and reduced inflammatory stress on the body.These shifts support sustainable, long-term health rather than temporary results
People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications
Healthy aging and muscle function are positively associated with NAD+ abundance in humans
Injections can bypass the digestive system, ensuring adequate absorption